𝛼SK or Searchbullish
Island Pharmaceuticals Ltd - Bundibugyo Ebola outbreak accelerates
SUMMARY
- Island Pharmaceuticals Ltd (ASX:ILA) is an antiviral therapeutics company targeting infectious diseases.
- As detailed in our previous note, the unfortunate Bundibugyo Ebola outbreak currently in Africa has provided an opportunity for ILA to provide compassionate use of its drug Galidesivir as a treatment for infected patients, noting that no approved treatment currently exists for this particular strain of Ebola.
- This effectively provides a second pathway for Galidesivir to potentially be approved by the FDA, given that real-world clinical deployment allows for the opportunity to generate prospective human efficacy, safety and virological data.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Island Pharmaceuticals Ltd - Bundibugyo Ebola outbreak accelerates03 Aug 2026
x